Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Cerenkov Luminescence Imaging as a Modality to Evaluate Antibody-Based PET Radiotracers.

D'Souza JW, Hensley H, Doss M, Beigarten C, Torgov M, Olafsen T, Yu JQ, Robinson MK.

J Nucl Med. 2017 Jan;58(1):175-180. doi: 10.2967/jnumed.116.178780. Epub 2016 Aug 18.

2.

A DLL3-targeted antibody-drug conjugate eradicates high-grade pulmonary neuroendocrine tumor-initiating cells in vivo.

Saunders LR, Bankovich AJ, Anderson WC, Aujay MA, Bheddah S, Black K, Desai R, Escarpe PA, Hampl J, Laysang A, Liu D, Lopez-Molina J, Milton M, Park A, Pysz MA, Shao H, Slingerland B, Torgov M, Williams SA, Foord O, Howard P, Jassem J, Badzio A, Czapiewski P, Harpole DH, Dowlati A, Massion PP, Travis WD, Pietanza MC, Poirier JT, Rudin CM, Stull RA, Dylla SJ.

Sci Transl Med. 2015 Aug 26;7(302):302ra136. doi: 10.1126/scitranslmed.aac9459.

3.

Pharmacologically enhanced expression of GPNMB increases the sensitivity of melanoma cells to the CR011-vcMMAE antibody-drug conjugate.

Qian X, Mills E, Torgov M, LaRochelle WJ, Jeffers M.

Mol Oncol. 2008 Jun;2(1):81-93. doi: 10.1016/j.molonc.2008.02.002. Epub 2008 Feb 16.

4.

Treatment parameters modulating regression of human melanoma xenografts by an antibody-drug conjugate (CR011-vcMMAE) targeting GPNMB.

Pollack VA, Alvarez E, Tse KF, Torgov MY, Xie S, Shenoy SG, MacDougall JR, Arrol S, Zhong H, Gerwien RW, Hahne WF, Senter PD, Jeffers ME, Lichenstein HS, LaRochelle WJ.

Cancer Chemother Pharmacol. 2007 Aug;60(3):423-35. Epub 2007 Jun 1.

PMID:
17541593
5.

Potent cytotoxicity of an auristatin-containing antibody-drug conjugate targeting melanoma cells expressing melanotransferrin/p97.

Smith LM, Nesterova A, Alley SC, Torgov MY, Carter PJ.

Mol Cancer Ther. 2006 Jun;5(6):1474-82.

6.

Reduction-alkylation strategies for the modification of specific monoclonal antibody disulfides.

Sun MM, Beam KS, Cerveny CG, Hamblett KJ, Blackmore RS, Torgov MY, Handley FG, Ihle NC, Senter PD, Alley SC.

Bioconjug Chem. 2005 Sep-Oct;16(5):1282-90.

7.

Generation of an intensely potent anthracycline by a monoclonal antibody-beta-galactosidase conjugate.

Torgov MY, Alley SC, Cerveny CG, Farquhar D, Senter PD.

Bioconjug Chem. 2005 May-Jun;16(3):717-21.

PMID:
15898742
8.

Novel antitumor prodrugs designed for activation by matrix metalloproteinases-2 and -9.

Kline T, Torgov MY, Mendelsohn BA, Cerveny CG, Senter PD.

Mol Pharm. 2004 Jan 12;1(1):9-22.

PMID:
15832497
9.

Design, synthesis, and in vitro evaluation of dipeptide-based antibody minor groove binder conjugates.

Jeffrey SC, Torgov MY, Andreyka JB, Boddington L, Cerveny CG, Denny WA, Gordon KA, Gustin D, Haugen J, Kline T, Nguyen MT, Senter PD.

J Med Chem. 2005 Mar 10;48(5):1344-58.

PMID:
15743178
10.

Development of potent monoclonal antibody auristatin conjugates for cancer therapy.

Doronina SO, Toki BE, Torgov MY, Mendelsohn BA, Cerveny CG, Chace DF, DeBlanc RL, Gearing RP, Bovee TD, Siegall CB, Francisco JA, Wahl AF, Meyer DL, Senter PD.

Nat Biotechnol. 2003 Jul;21(7):778-84. Epub 2003 Jun 1.

PMID:
12778055
11.

In vitro reconstitution of the bacteriophage T4 clamp loader complex (gp44/62).

Janzen DM, Torgov MY, Reddy MK.

J Biol Chem. 1999 Dec 10;274(50):35938-43.

12.
13.
14.

[Structure-activity study of the basic toxic component of venom from the ant Ectatomma tuberculatum].

Pluzhinikov KA, Nol'de DE, Tertyshnikova SM, Sukhanov SV, Sobol' AG, Torgov MIu, Filippov AK, Arsen'ev AS, Grishin EV.

Bioorg Khim. 1994 Aug-Sep;20(8-9):857-71. Russian.

PMID:
7826413
15.

Toxic principle of selva ant venom is a pore-forming protein transformer.

Arseniev AS, Pluzhnikov KA, Nolde DE, Sobol AG, Torgov MYu, Sukhanov SV, Grishin EV.

FEBS Lett. 1994 Jun 27;347(2-3):112-6.

16.

[Transformation of steroids by some thermophilic microorganisms].

Kogan LM, Volkova IM, Bukhar MI, Agre NS, Zviagintseva IS, Tsurkova VI, Torgov MV, Skriabin GK.

Mikrobiologiia. 1968 Jul-Aug;37(4):628-35. Russian. No abstract available.

PMID:
5734409

Supplemental Content

Loading ...
Support Center